APA (7th ed.) Citation

M, M., K, T., E, M., L, R., R, B., M, D., & R, L. (2026). Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines. The American journal of gastroenterology. https://doi.org/10.14309/ajg.0000000000004091

Chicago Style (17th ed.) Citation

M, Mironova, Tesfai K, Madamba E, Richards L, Bettencourt R, Docherty M, and Loomba R. "Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines." The American Journal of Gastroenterology 2026. https://doi.org/10.14309/ajg.0000000000004091.

MLA (9th ed.) Citation

M, Mironova, et al. "Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines." The American Journal of Gastroenterology, 2026, https://doi.org/10.14309/ajg.0000000000004091.